Zenas BioPharma (ZBIO) Other Non-Current Assets (2023 - 2026)

Zenas BioPharma's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $15.1 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 7105.74% year-over-year to $15.1 million; the TTM figure through Mar 2026 stood at $15.1 million (up 7105.74% YoY), while the FY2025 annual figure was $218000.0, down 98.28% from the prior year.
• Other Non-Current Assets was $15.1 million for Q1 2026 at Zenas BioPharma, up from $218000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $15.1 million in Q1 2026 to a low of $86000.0 in Q3 2023.
• Historically, Other Non-Current Assets has averaged $7.4 million across 4 years, with a median of $8.8 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets slumped 98.28% in 2025, then surged 7105.74% in 2026.
• A 4-year view of Other Non-Current Assets shows it stood at $5.8 million in 2023, then soared by 118.37% to $12.6 million in 2024, then plunged by 98.28% to $218000.0 in 2025, then soared by 6808.26% to $15.1 million in 2026.
• The last three Other Non-Current Assets figures came in at $15.1 million (Q1 2026), $218000.0 (Q4 2025), and $13.8 million (Q3 2025), per Business Quant data.